SI1989231T1 - Kombinacijska terapija, ki vključuje alfa5beta 1 antagoniste - Google Patents

Kombinacijska terapija, ki vključuje alfa5beta 1 antagoniste

Info

Publication number
SI1989231T1
SI1989231T1 SI200731683T SI200731683T SI1989231T1 SI 1989231 T1 SI1989231 T1 SI 1989231T1 SI 200731683 T SI200731683 T SI 200731683T SI 200731683 T SI200731683 T SI 200731683T SI 1989231 T1 SI1989231 T1 SI 1989231T1
Authority
SI
Slovenia
Prior art keywords
antagonists
therapy involving
combinatorial therapy
combinatorial
involving
Prior art date
Application number
SI200731683T
Other languages
English (en)
Inventor
Anan Chuntharapai
Greg Plowman
Marc Tessier-Lavigne
Yan Wu
Weilan Ye
Original Assignee
Genentech, Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech, Inc., filed Critical Genentech, Inc.,
Priority claimed from PCT/US2007/064572 external-priority patent/WO2008060645A2/en
Publication of SI1989231T1 publication Critical patent/SI1989231T1/sl

Links

SI200731683T 2006-03-21 2007-03-21 Kombinacijska terapija, ki vključuje alfa5beta 1 antagoniste SI1989231T1 (sl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US78470406P 2006-03-21 2006-03-21
US78533006P 2006-03-22 2006-03-22
US87174306P 2006-12-22 2006-12-22
PCT/US2007/064572 WO2008060645A2 (en) 2006-03-21 2007-03-21 Combinatorial therapy involving alpha5beta1 antagonists
EP07868188.9A EP1989231B1 (en) 2006-03-21 2007-03-21 Combinatorial therapy involving alpha5beta1 antagonists

Publications (1)

Publication Number Publication Date
SI1989231T1 true SI1989231T1 (sl) 2015-10-30

Family

ID=40743758

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200731683T SI1989231T1 (sl) 2006-03-21 2007-03-21 Kombinacijska terapija, ki vključuje alfa5beta 1 antagoniste

Country Status (3)

Country Link
CN (1) CN101448858B (sl)
SI (1) SI1989231T1 (sl)
ZA (1) ZA200807754B (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010111254A1 (en) * 2009-03-25 2010-09-30 Genentech, Inc. Novel anti-alpha5beta1 antibodies and uses thereof
ES2699532T3 (es) * 2011-03-23 2019-02-11 Univ California Métodos y composiciones para mejorar la terapia antiangiogénica con anti-integrinas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316670A (pt) * 2002-11-26 2005-10-11 Protein Design Labs Inc Anticorpos quiméricos e humanizados para integrina (alfa)5ß1 que modulam a angiogênese

Also Published As

Publication number Publication date
ZA200807754B (en) 2009-12-30
CN101448858B (zh) 2013-06-12
CN101448858A (zh) 2009-06-03

Similar Documents

Publication Publication Date Title
PL1989231T3 (pl) Terapia kombinatoryczna z udziałem antagonistów alfa5beta1
GB2436905B (en) Vibrator
GB2438255B (en) Vibrator
GB0609492D0 (en) Therapeutic agents
GB0608928D0 (en) Therapeutic agents
GB0601962D0 (en) Therapeutic agents
GB0700345D0 (en) Vibrator
IL197818A0 (en) Multiple sclerosis therapy
GB0616214D0 (en) Therapeutic Agents
IL196556A0 (en) Combination therapy
EP2054061A4 (en) COMBINATION THERAPY
GB0611152D0 (en) Therapeutic agents
GB0620818D0 (en) Therapeutic agents
IL198026A0 (en) Sequential combination therapy
GB0620059D0 (en) Therapeutic agents
GB0609121D0 (en) Peptide Therapy
EP2076239A4 (en) COMBINATION THERAPY
GB0609676D0 (en) Therapeutic agents
ZA200903523B (en) Poly-TLR antagonist
IL193427A0 (en) Polypeptide antagonist
ZA200807754B (en) Combinatorial therapy involving alpha5beta1 antagonists
GB0622195D0 (en) Therapeutic agents
GB0603430D0 (en) Therapy
GB0609414D0 (en) Therapy
GB0607158D0 (en) Therapy